<table className="table">
  <caption>
    <p>
      Characteristics of High Altitudeâ€“Related Illness Syndromes
    </p>
  </caption>
  <thead>
    <tr>
      <th rowSpan="1" colSpan="1">
        <p>
          Illness
        </p>
      </th>
      <th rowSpan="1" colSpan="1">
        <p>
          Elevation Level
        </p>
      </th>
      <th rowSpan="1" colSpan="1">
        <p>
          Symptoms
        </p>
      </th>
      <th rowSpan="1" colSpan="1">
        <p>
          Treatment
        </p>
      </th>
      <th rowSpan="1" colSpan="1">
        <p>
          Prevention
        </p>
      </th>
    </tr>
  </thead>
  <tbody>
    <tr className="group_1-1 row-odd">
      <td rowSpan="1" colSpan="1">
        <p>
          Acute mountain sickness
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          2000 to 2500 m
        </p>
        <p>
          (6500 to 8200 ft)
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Nonspecific; headache, malaise, anorexia, nausea, vomiting
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Supplemental oxygen, acetazolamide, dexamethasone, descent from altitude; aspirin or NSAID for headache
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Gradual ascent (&lt;500 m/d [1600 ft/d]) at high altitude; prophylaxis with acetazolamide or dexamethasone for rapid ascent or in patients at high risk
        </p>
      </td>
    </tr>
    <tr className="group_1-2 row-even">
      <td rowSpan="1" colSpan="1">
        <p>
          High-altitude cerebral edema
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          3000 to 4000 m
        </p>
        <p>
          (10,000 to 13,000 ft)
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Confusion, irritability, ataxic gait, coma, death
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Descent from altitude, dexamethasone, supplemental oxygen, hyperbaric therapy
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Gradual ascent; consider acetazolamide or dexamethasone in patients at high risk
        </p>
      </td>
    </tr>
    <tr className="group_1-3 row-odd">
      <td rowSpan="1" colSpan="1">
        <p>
          High-altitude pulmonary edema
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          &gt;2500 m
        </p>
        <p>
          (&gt;8200 ft)
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Cough, exertional intolerance, dyspnea at rest, frothy sputum
        </p>
        <p>
          (2-4 d after arrival at new altitude)
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Supplemental oxygen and descent from altitude; adjunctive therapy: nifedipine, phosphodiesterase-5 inhibitors
        </p>
        <p>
          Diuretics and nitrates not recommended
        </p>
        <p>
          Intubation may be required
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Gradual ascent; consider nifedipine in patients at high risk
        </p>
      </td>
    </tr>
  </tbody>
</table>
